Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | STAT3 | P40763 | 1/20 | 0.33 |
| ▸ | MET | P08581 | 1/20 | 0.31 |
| ▸ | TAS2R46 | P59540 | 4/20 | 0.31 |
| ▸ | TAS2R31 | P59538 | 2/20 | 0.31 |
| ▸ | TAS2R10 | Q9NYW0 | 2/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
| ▸ | PPARA | Q07869 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3851126 | 1.00 | LMNA (0.44) | LMNAPTPN1MEN1KMT2ACYP3A4 | |
| SCHEMBL6882235 | 1.00 | LMNA (0.44) | LMNAPTPN1MEN1KMT2ACYP3A4 | |
| SCHEMBL5933973 | 1.00 | LMNA (0.44) | LMNAPTPN1MEN1KMT2ACYP3A4 | |
| SCHEMBL736990 | 1.00 | LMNA (0.44) | LMNAPTPN1MEN1KMT2ACYP3A4 | |
| Bicarbonate SCHEMBL17847277 | 0.90 | LMNA (0.42) | LMNAPTPN1MEN1KMT2ACYP3A4 | |
| SCHEMBL8813386 | 0.89 | LMNA (0.37) | LMNAPTPN1TAS2R46TAS2R31TAS2R10 | |
| D-Limonene SCHEMBL4609927 | 0.83 | LMNA (0.75) | LMNAMEN1KMT2ACYP3A4ALOX15 | |
| SCHEMBL6402023 | 0.83 | LMNA (0.46) | LMNAPTPN1MEN1KMT2ACYP3A4 | |
| SCHEMBL1704609 | 0.83 | LMNA (0.46) | LMNAPTPN1MEN1KMT2ACYP3A4 | |
| SCHEMBL14764978 | 0.83 | LMNA (0.41) | LMNAPTPN1MEN1KMT2ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250090554-A1 | A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION | MYND LIFE SCIENCES INC (CA) | 2025-03-20 | — | — | US | disclosed |
| EP-3923917-A1 | PROCESS FOR THE SYNTHESIS OF CANNABIDIOL AND INTERMEDIATES THEREOF | Council of Scientific & Industrial Research, an Indian registered body incorporated under the Registration of Societies Act (Act XXI of 1860) (IN) | 2021-12-22 | — | — | EP | disclosed |
| WO-2021181420-A1 | PROCESS FOR THE SYNTHESIS OF CANNABIDIOL AND INTERMEDIATES THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860) (IN) | 2021-09-16 | — | — | WO | disclosed |
| EP-3079679-A1 | METHOD OF TREATMENT OF ALOPECIA WITH MONOTERPENOIDS | Cellmid Limited (AU) | 2016-10-19 | — | — | EP | disclosed |
| WO-2015085373-A1 | METHOD OF TREATMENT OF ALOPECIA WITH MONOTERPENOIDS | Cellmid Limited (AU) | 2015-06-18 | — | — | WO | disclosed |